标普生物科技LOF(161127)
动态评分： 5.92分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2023-12-31 | VIR | Vir Biotechnology Inc | 152.66 | 0.48% |
| 2023-12-31 | REPL | Replimune Group Inc | 147.71 | 0.47% |
| 2023-12-31 | INBX | Inhibrx Inc | 148.35 | 0.47% |
| 2023-12-31 | MIRM | Mirum Pharmaceuticals Inc | 146.38 | 0.46% |
| 2023-12-31 | PTGX | Protagonist Therapeutics Inc | 145.47 | 0.46% |
| 2023-12-31 | TVTX | Travere Therapeutics Inc | 145.88 | 0.46% |
| 2023-12-31 | VCEL | Vericel Corp | 143.33 | 0.45% |
| 2023-12-31 | IBRX | ImmunityBio Inc | 140.42 | 0.44% |
| 2023-12-31 | EDIT | Editas Medicine Inc | 137.28 | 0.43% |
| 2023-12-31 | RLAY | Relay Therapeutics Inc | 136.36 | 0.43% |
| 2023-12-31 | ARCT | Arcturus Therapeutics Holdings Inc | 134.93 | 0.43% |
| 2023-12-31 | GERN | 杰龙 | 133.95 | 0.42% |
| 2023-12-31 | AGIO | Agios Pharmaceuticals Inc | 130.02 | 0.41% |
| 2023-12-31 | DAWN | Day One Biopharmaceuticals Holding Co LLC | 130.48 | 0.41% |
| 2023-12-31 | MYGN | 万基遗传 | 124.05 | 0.39% |
| 2023-12-31 | KYMR | Kymera Therapeutics Inc | 115.7 | 0.37% |
| 2023-12-31 | MNKD | 曼恩凯德生物医疗 | 112.46 | 0.36% |
| 2023-12-31 | KROS | Keros Therapeutics Inc | 98.14 | 0.31% |
| 2023-12-31 | VERA | Vera Therapeutics Inc-A | 99.31 | 0.31% |
| 2023-12-31 | CDMO | Avid Bioservices Inc | 93.68 | 0.3% |
公告&资料
